Robeco Capital Growth Funds-Robeco BP US Premium Equities ClassD USD
Robeco Capital Growth Funds (SICAV domiciled in Luxembourg)
Key Information
Legal Documents
Performance
Analysis

Fund Profile

Category: SICAV

Robeco BP US Premium Equities is a fund that invests across market capitalizations and sectors in a flexible manner. The selection of these stocks is based on fundamental analysis. The portfolio is consistently built from the bottom up to exhibit attractive valuation, strong business fundamentals and improving business momentum. Investments are predominantly made in securities denominated in US dollars. The fund is not constrained by a benchmark. This share class of the fund does not distribute dividend. You can purchase or sell units in the fund on any valuation day. This fund may not be appropriate for investors who plan to withdraw their money within 5 years.

Morningstar Rating
More information about the calculation of the Morningstar Ratings
Silver
Silver
Risk and reward profile
5
Lower Risk
Possible Lower
Returns
Higher Risk
Possible Higher
Returns
Key Information
Closing Price 21/09/2020250.50
Morningstar categoryUS Large-Cap Value Equity
CurrencyUSD
Distribution statusAccumulating
ISINLU0226953718
Inception Date03/10/2005
Minimum initial amount100.00 USD
Fees And Charges
Entry feeNone
Custody feeNone
Exit feeNone
Ongoing charge1.71% of which 0.75% is paid to MeDirect
Fund management company
AddressRobeco Luxembourg SA 5, rue Heienhaff L-1736 Senningerberg Luxembourg L-1736 Luxembourg
Manager NameDuilio R. Ramallo
Manager Start Date03/10/2005
Websitewww.robeco.com
Total Net Assets (mil)3,644.82 USD (31/08/2020)
UCITSYes
AdministratorJ.P. Morgan Bank Luxembourg S.A.

Documents

Prospectus
en 01/08/2020
Annual Report
en 31/12/2019
Semi Annual Report
en 30/06/2019
Morningstar Report
23/09/2020

Performance

Historical returns are no guarantee for future performances. Investing in Financial markets and securities involves risk. Past performance is not a guarantee of future results. Investment losses may occur and investors could lose some or all of their investment in the Fund.
Entry fees, purchase charges, custody fees, exit fees, sale charges and taxes are not included in the calculation of past performance. Ongoing charges (including management fees, administrative fees and other costs) have been taken in to account, as they are already included in the price/NAV of the fund.
The performance in euro can be lower or higher than the performance in the currency of denomination of the fund due to fluctuations in exchange rates.
Annualised performance in USD
PeriodAnnualised returnDate
1 year-7.68%21/09/2020
3 years-0.05%21/09/2020
5 years5.19%21/09/2020
10 years8.62%21/09/2020
Since launch8.31%21/09/2020
Cumulative performance in USD
Performance
YTD 01/01/2020-14.51
1 month-2.37
3 months2.20
6 months37.09
Quarterly Returns
Q 1Q 2Q 3Q 4
2020-29.01%15.98%--
201912.41%5.06%-0.54%8.86%
2018-0.84%-0.30%5.51%-17.32%
20174.82%2.42%3.83%4.69%
2016-2.42%3.08%6.27%4.92%
Dividend

Asset Allocation
% Long% Short% Net Assets
Stock96.70%0.00%96.70%
Bond0.00%0.00%0.00%
Cash7.97%4.68%3.30%
Other0.00%0.00%0.00%
Return/Risk Analysis
Risk Measurement1 Year3 Years5 Years
Standard Deviation
26.9520.1917.38
Sharpe Ratio
0.090.120.34
Sortino Ratio
0.110.150.47
Positive Months8.0023.0038.00
Negative Months4.0013.0022.00
Worst Month-17.99-17.99-17.99
World Regions
Region%
United States89.26
Europe - ex Euro3.57
United Kingdom1.07
Asia - Developed0.90
Asia - Emerging0.89
Canada0.57
Latin America0.44
Eurozone0.00
Stock Sector Weighting
Sector% of Equity
Healthcare24.11
Financial Services22.36
Industrials12.95
Technology12.92
Consumer Cyclical
7.92
Communication Services6.40
Basic Materials5.76
Energy2.46
Consumer Defensive
1.32
Utilities0.49
Top 10 Holdings
HoldingSectorCountry% of Assets
Pfizer Inc HealthcareUnited States2.12
Bank of America Corp Financial ServicesUnited States2.06
Johnson & Johnson HealthcareUnited States2.01
Qorvo Inc TechnologyUnited States1.94
Medtronic PLC HealthcareUnited States1.89
JPMorgan Chase & Co Financial ServicesUnited States1.85
Novartis AG ADR HealthcareSwitzerland1.59
Citigroup Inc Financial ServicesUnited States1.50
UnitedHealth Group Inc HealthcareUnited States1.48
Oracle Corp TechnologyUnited States1.45
Classification of Morningstar Category
Ranking1 Year2 Years3 Years5 Years
Top 25%
Category above the average
Category below the average
Bottom 25%
Morningstar Style Box
Equity Style
Large
Size
Mid
Small
Value
Blend
Growth
Style
$
250.50
Closing Price
All key information and documents must be reviewed before being able to Invest.